
Posted on 7月 14, 20217/14/21
Navigating the Transition to Post-Approval Pharmacovigilance With EVERSANA and ArisGlobal

Posted on 7月 13, 20217/13/21
Case Study: Launching a New Therapy for HER2-Positive Metastatic Breast Cancer

Posted on 7月 12, 20217/12/21
Global Regulations Push Accelerated Approvals, Access and Treatment Distribution: June 2021

Posted on 6月 29, 20216/29/21
A SpaceX Philosophy to Launching in Pharma

Posted on 6月 23, 20216/23/21
Considering a Virtual Advisory Board as a Viable, Cost-Effective Option for PMR Planning

Posted on 6月 23, 20216/23/21
The Rise of Digital Therapeutics Opportunities in China

Posted on 6月 16, 20216/16/21
Global Pharma Heads Into Uncharted Territories in Pricing and Regulation: May 2021

Posted on 6月 15, 20216/15/21
PharmaVOICE Webinar: Next Gen Commercialization Model for Oncology

Posted on 5月 28, 20215/28/21
Informing NAMs Payer Strategies and Improving Contracts With Integrated Commercial Services

Posted on 5月 28, 20215/28/21